Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001621170-14-000001
Filing Date
2014-10-16
Accepted
2014-10-16 13:12:28
Documents
1
Period of Report
2014-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3642
  Complete submission text file 0001621170-14-000001.txt   5111
Mailing Address 1800 WYOMING AVENUE, NW, 3RD FLOOR WASHINGTON, DC X1 20009
Business Address 1800 WYOMING AVENUE, NW, 3RD FLOOR WASHINGTON, DC X1 20009 1-888-267-1175
Immunoclin Corp (Issuer) CIK: 0001520047 (see all company filings)

EIN.: 320337695 | State of Incorp.: NV | Fiscal Year End: 0131
SIC: 7374 Services-Computer Processing & Data Preparation

Mailing Address TANGLEWOOD, NORTH DEAN HIGH WYCOMBE X0 HP14 4NN
Business Address
Bray DH (Reporting) CIK: 0001621170 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54738 | Film No.: 141159329